bioRxiv Science⌕ Search

Biology subjects

Khurram, N.

Publications and source records attributed to Khurram, N..

2 recordsLinked to original sources

Transcriptional divergence of the zebrafish sox17 lineage begins during gastrulation

The endoderm is specified at the onset of gastrulation and subsequently undergoes extensive migration before forming an epithelial sheet that gives rise to multiple organs, including the gut and respiratory tracts. Although the gene regulatory network underlying endoderm specification and the later processes that regionalize the gut are increasingly well understood, comparatively little is known about the intervening developmental events. Using single cell transcriptomics, we profiled the zebrafish sox17 lineage, comprising endoderm and dorsal forerunner cells, throughout and immediately after gastrulation. We found that dorsal forerunner cells remain transcriptionally homogeneous while undergoing coordinated temporal changes, associated with ciliogenesis and epithelial organization, during assembly of Kupffers vesicle. In contrast, endoderm cells transition from a migratory to an epithelial transcriptional state while progressively acquiring distinct regional identities. These findings indicate that endoderm regionalization emerges within the context of a broadly shared transcriptional program associated with migration and epithelialization.

Developmental Biology↗

Superiority of intranasal over systemic administration of bioengineered soluble ACE2 for survival and brain protection against SARS-CoV-2 infection

The present study was designed to investigate the effects of a soluble ACE2 protein termed ACE2 618-DDC-ABD, bioengineered to have long duration of action and high binding affinity to SARS-CoV-2, when administered either intranasally (IN) or intraperitoneally (IP) and before or after SARS-CoV-2 inoculation. K18hACE2 mice permissive for SARS-CoV-2 infection were inoculated with 2x104 PFU wildtype SARS-CoV-2. In one protocol, ACE2 618-DDC-ABD was given either IN or IP, pre- and post-viral inoculation. In a second protocol, ACE2 618-DDC-ABD was given either IN, IP or IN+IP but only post-viral inoculation. In addition, A549 and Vero E6 cells were used to test neutralization of SARS-CoV-2 variants by ACE2 618-DDC-ABD at different concentrations. Survival by day 5 was 0% in infected untreated mice, and 40% in mice from the ACE2 618-DDC-ABD IP-pre treated group. By contrast, in the IN-pre group survival was 90%, histopathology of brain and kidney was essentially normal and markedly improved in the lungs. When ACE2 618-DDC-ABD was administered only post viral inoculation, survival was 30% in the IN+IP group, 20% in the IN and 0% in the IP group. Brain SARS-CoV-2 titers were high in all groups except for the IN-pre group where titers were undetectable in all mice. In cells permissive for SARS-CoV-2 infection, ACE2 618-DDC-ABD neutralized wildtype SARS-CoV-2 at high concentrations, whereas much lower concentrations neutralized omicron BA. 1. We conclude that ACE2 618-DDC-ABD provides much better survival and organ protection when administered intranasally than when given systemically or after viral inoculation and that lowering brain titers is a critical determinant of survival and organ protection.

pathology↗